Cytomegalovirus retinitis

Ophthalmology. 2009 Apr;116(4):817-8; author reply 818-9. doi: 10.1016/j.ophtha.2008.12.010.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • Alemtuzumab
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm / adverse effects*
  • Antibodies, Viral / blood
  • Aqueous Humor / virology
  • Cytomegalovirus / genetics
  • Cytomegalovirus / immunology
  • Cytomegalovirus / isolation & purification
  • Cytomegalovirus Retinitis / drug therapy
  • Cytomegalovirus Retinitis / etiology*
  • Drug Therapy, Combination
  • Foscarnet / therapeutic use
  • Ganciclovir / therapeutic use
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Lymphoma, T-Cell / complications
  • Lymphoma, T-Cell / physiopathology
  • Male
  • Middle Aged
  • Opportunistic Infections / drug therapy
  • Opportunistic Infections / etiology*
  • Polymerase Chain Reaction
  • Transplantation Conditioning / adverse effects*
  • Transplantation, Homologous
  • Visual Acuity
  • Vitreous Body / virology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Antibodies, Viral
  • Foscarnet
  • Alemtuzumab
  • Ganciclovir